TRPM channels in human cancers: regulatory mechanism and therapeutic prospects

Qinfeng Liu1, Mengyu Hu1, Shi Li1

  • 1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan, 430074, China.

Biomarker Research
|December 5, 2024
PubMed

Insights

Transient Receptor Potential Melastatin (TRPM) channels are increasingly linked to cancer, influencing tumor growth and metastasis. Targeting TRPM channels offers potential new strategies for cancer treatment and immunotherapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Ion Channel Physiology

Background:

  • Transient Receptor Potential Melastatin (TRPM) channels are implicated in diseases, including cancer.
  • TRPM channels exhibit both pro- and anti-tumorigenic functions in various malignancies.
  • They are involved in tumor cell proliferation, survival, invasion, and metastasis, acting as potential biomarkers.

Purpose of the Study:

  • To describe the structure and physiological functions of TRPM channel family members.
  • To outline the roles of TRPM channels in common cancers like pancreatic, prostate, colorectal, breast, brain cancer, and melanoma.
  • To investigate the mechanisms of TRPM channel involvement in tumorigenesis from the tumor microenvironment and intracellular signaling.

Main Methods:

  • Literature review and analysis of existing research on TRPM channels in cancer.
  • Examination of TRPM channel involvement in tumor cell functions, including proliferation, survival, invasion, and metastasis.
  • Analysis of TRPM channel roles in signaling pathways (Wnt/β-catenin, MAPK, PI3K/AKT, p53, autophagy) and the tumor microenvironment.

Main Results:

  • TRPM channels are involved in tumor cell proliferation, survival, invasion, and metastasis.
  • They mediate extracellular matrix remodeling, aiding malignant transformation.
  • TRPM channels regulate ion inflow and participate in key cancer signaling pathways.

Conclusions:

  • TRPM channels are crucial in cancer development and progression.
  • Targeting TRPM channels presents therapeutic opportunities and challenges in cancer treatment.
  • Combining TRPM channel-targeted drugs with cancer immunotherapy is a promising future direction.

Related Concept Videos

Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K